Product Information

PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1111 per EA under NDC 57237022130. Its NADAC has been published 459 times since Nov 8, 2017.

FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 45 MG TABLET

Pioglitazone
$0.1111per EA

Strength

45 mg/1

NDC

57237022130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA200268

FDA Approved

2/13/2013

TE Code

AB

On Market Since

2/13/2013

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 459 times since Nov 8, 2017, and over the history we have for it it has declined 34.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1111 per EA
All-time high$0.1794 (Jan 13, 2021)
All-time low$0.0964 (Nov 20, 2024)
52-week high$0.1277
52-week low$0.1111
Median price$0.1395
Average price$0.1407
Largest weekly change-26.2% (Nov 20, 2024)
Weeks tracked459
Tracking sinceNov 8, 2017

Price History

1W

-1.4%

1M

-1.4%

3M

-7.1%

6M

-1.1%

1Y

-12.9%

3Y

-16.6%

5Y

-37.3%

All

-34.2%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1111 per EA (NDC 57237022130), effective Aug 19, 2026.

How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has declined 34.2%. It has been tracked across 459 weekly CMS publications since Nov 8, 2017.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?

Since Nov 8, 2017, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.0964 (Nov 20, 2024) to a high of $0.1794 (Jan 13, 2021), with a median of $0.1395 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 45 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 45 MG TABLET?

PIOGLITAZONE HCL 45 MG TABLET (NDC 57237022130) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.